CCT369260 (compound 1) 是具有口服活性的、B 细胞淋巴瘤 6 (BCL6) 抑制剂，具有抗肿瘤活性，其 IC50 值为 520 nM。
货号:ajcx33966
CAS:N/A
分子式:C24H31ClF2N6O2
分子量：508.99
溶解度:DMSO : 300 mg/mL (589.40 mM; Need ultrasonic)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

CCT369260 (compound 1) is an orally avtive B-cell lymphoma 6 (BCL6) inhibitor with anti-tumor activity. CCT369260 (compound 1) exhibits an IC50 of 520 nM[1].

CCT369260 (compound 1, 15 mg/kg, po, single dose) significantly inhibits BCL6 in OCI-Ly1 DLBCL xenograft model[1].

[1]. Benjamin R Bellenie, et al. Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders. J Med Chem. 2020 Apr 23;63(8):4047-4068.